Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.
Huang Z, Zeng L, Ruan Z, Zeng Q, Yan H, Jiang W, Xiong Y, Zhou C, Yang H, Liu L, Dai J, Zou N, Xu S, Wang Y, Wang Z, Deng J, Chen X, Wang J, Xiang H, Li X, Duchemann B, Chen G, Xia Y, Mok T, Scheiermann C, Lévi F, Yang N, Zhang Y.
Huang Z, et al. Among authors: zeng q.
Nat Med. 2026 Feb 2. doi: 10.1038/s41591-025-04181-w. Online ahead of print.
Nat Med. 2026.
PMID: 41629425